Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Przeglądasz jako GOŚĆ

Wyszukujesz frazę ""Frontiers in oncology [Front Oncol] NLMUID: 101568867"" wg kryterium: JN


Tytuł :
β-Lapachone Selectively Kills Hepatocellular Carcinoma Cells by Targeting NQO1 to Induce Extensive DNA Damage and PARP1 Hyperactivation.
Autorzy :
Zhao W; Department of Radiation Oncology, Melvin and Bren Simon Comprehensive Cancer Center, Indiana University School of Medicine, Indianapolis, IN, United States.; Fujian Provincial Key Laboratory of Chronic Liver Disease and Hepatocellular Carcinoma, Zhongshan Hospital, Xiamen University, Xiamen, China.
Jiang L; Department of Radiation Oncology, Melvin and Bren Simon Comprehensive Cancer Center, Indiana University School of Medicine, Indianapolis, IN, United States.
Fang T; Fujian Provincial Key Laboratory of Chronic Liver Disease and Hepatocellular Carcinoma, Zhongshan Hospital, Xiamen University, Xiamen, China.
Fang F; Fujian Provincial Key Laboratory of Chronic Liver Disease and Hepatocellular Carcinoma, Zhongshan Hospital, Xiamen University, Xiamen, China.
Liu Y; Departments of Biochemistry and Molecular Biology, Melvin and Bren Simon Comprehensive Cancer Center, Indiana University School of Medicine, Indianapolis, IN, United States.
Zhao Y; Departments of Biochemistry and Molecular Biology, Melvin and Bren Simon Comprehensive Cancer Center, Indiana University School of Medicine, Indianapolis, IN, United States.
You Y; Fujian Provincial Key Laboratory of Chronic Liver Disease and Hepatocellular Carcinoma, Zhongshan Hospital, Xiamen University, Xiamen, China.
Zhou H; Department of Radiation Oncology, Melvin and Bren Simon Comprehensive Cancer Center, Indiana University School of Medicine, Indianapolis, IN, United States.
Su X; Departments of Biochemistry and Molecular Biology, Melvin and Bren Simon Comprehensive Cancer Center, Indiana University School of Medicine, Indianapolis, IN, United States.
Wang J; Department of Radiation Oncology, Melvin and Bren Simon Comprehensive Cancer Center, Indiana University School of Medicine, Indianapolis, IN, United States.
Liu S; Department of Medical and Molecular Genetics, Indiana University School of Medicine, Indianapolis, IN, United States.
Chen Y; Indiana University Health Pathology Laboratory, Indiana University School of Medicine, Indianapolis, IN, United States.
Wan J; Department of Medical and Molecular Genetics, Indiana University School of Medicine, Indianapolis, IN, United States.; Center for Computational Biology and Bioinformatics, Indiana University, School of Medicine, Indianapolis, IN, United States.
Huang X; Department of Radiation Oncology, Melvin and Bren Simon Comprehensive Cancer Center, Indiana University School of Medicine, Indianapolis, IN, United States.
Pokaż więcej
Źródło :
Frontiers in oncology [Front Oncol] 2021 Oct 05; Vol. 11, pp. 747282. Date of Electronic Publication: 2021 Oct 05 (Print Publication: 2021).
Typ publikacji :
Journal Article
Czasopismo naukowe
Tytuł :
Long-Term Response to Gemcitabine, Cisplatin, and Nab-Paclitaxel Followed by Maintenance Therapy for Advanced Gallbladder Cancer: A Case Report and Literature Review.
Autorzy :
Liu T; Department of Biotherapy, Cancer Center, West China Hospital, Sichuan University, Chengdu, China.
Li Q; Cancer Center, West China Hospital, Sichuan University, Chengdu, China.
Zhang W; Department of Nuclear Medicine, West China Hospital, Sichuan University, Chengdu, China.
Zhu Q; Department of Abdominal Oncology, Cancer Center, West China Hospital, Sichuan University, Chengdu, China.
Pokaż więcej
Źródło :
Frontiers in oncology [Front Oncol] 2021 Oct 05; Vol. 11, pp. 733955. Date of Electronic Publication: 2021 Oct 05 (Print Publication: 2021).
Typ publikacji :
Case Reports
Raport
Tytuł :
Overexpression of Long Non-Coding RNA Linc01315 Predicts Poor Prognosis in Breast Cancer.
Autorzy :
Xue J; Key Laboratory of Breast Cancer in Shanghai, Department of Breast Surgery, Fudan University Shanghai Cancer Center, Shanghai, China.; Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, China.
Huang S; The 2nd Department of Breast Surgery, Breast Cancer Center of the Third Affiliated Hospital of Kunming Medical University, Tumor Hospital of Yunnan Province, Kunming, China.
Chen J; Department of Head and Neck Surgery, Fudan University Shanghai Cancer Center, Shanghai, China.
Chen YZ; Department of Thyroid and Breast Surgery, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, China.
Shao ZM; Key Laboratory of Breast Cancer in Shanghai, Department of Breast Surgery, Fudan University Shanghai Cancer Center, Shanghai, China.; Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, China.
Wu J; Key Laboratory of Breast Cancer in Shanghai, Department of Breast Surgery, Fudan University Shanghai Cancer Center, Shanghai, China.; Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, China.; Collaborative Innovation Center for Cancer Medicine, Shanghai Medical College, Fudan University, Shanghai, China.
Chi Y; Key Laboratory of Breast Cancer in Shanghai, Department of Breast Surgery, Fudan University Shanghai Cancer Center, Shanghai, China.; Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, China.
Pokaż więcej
Źródło :
Frontiers in oncology [Front Oncol] 2021 Oct 05; Vol. 11, pp. 562378. Date of Electronic Publication: 2021 Oct 05 (Print Publication: 2021).
Typ publikacji :
Journal Article
Czasopismo naukowe
Tytuł :
Identification of a Somatic Mutation-Derived Long Non-Coding RNA Signatures of Genomic Instability in Renal Cell Carcinoma.
Autorzy :
Fang X; Department of Medical Oncology, Guangzhou First People's Hospital, School of Medicine, South China University of Technology, Guangzhou, China.; Department of Medical Oncology, Guangzhou First People's Hospital, Guangzhou Medical University, Guangzhou, China.
Liu X; Department of Medical Oncology, Guangzhou First People's Hospital, School of Medicine, South China University of Technology, Guangzhou, China.; Department of Medical Oncology, Guangzhou First People's Hospital, Guangzhou Medical University, Guangzhou, China.
Lu L; Department of Medical Oncology, Guangzhou First People's Hospital, School of Medicine, South China University of Technology, Guangzhou, China.; Department of Medical Oncology, Guangzhou First People's Hospital, Guangzhou Medical University, Guangzhou, China.
Liu G; Department of Medical Oncology, Guangzhou First People's Hospital, School of Medicine, South China University of Technology, Guangzhou, China.; Department of Medical Oncology, Guangzhou First People's Hospital, Guangzhou Medical University, Guangzhou, China.
Pokaż więcej
Źródło :
Frontiers in oncology [Front Oncol] 2021 Oct 05; Vol. 11, pp. 728181. Date of Electronic Publication: 2021 Oct 05 (Print Publication: 2021).
Typ publikacji :
Journal Article
Czasopismo naukowe
Tytuł :
Dynamic F-FDopa PET Imaging for Newly Diagnosed Gliomas: Is a Semiquantitative Model Sufficient?
Autorzy :
Zaragori T; Department of Nuclear Medicine and Nancyclotep Imaging Platform, CHRU-Nancy, Université de Lorraine, Nancy, France.; IADI UMR 1254, INSERM, Université de Lorraine, Nancy, France.
Doyen M; Department of Nuclear Medicine and Nancyclotep Imaging Platform, CHRU-Nancy, Université de Lorraine, Nancy, France.; IADI UMR 1254, INSERM, Université de Lorraine, Nancy, France.
Rech F; Department of Neurosurgery, CHRU-Nancy, Université de Lorraine, Nancy, France.; Centre de Recherche en Automatique de Nancy CRAN UMR 7039, CNRS, Université de Lorraine, Nancy, France.
Blonski M; Centre de Recherche en Automatique de Nancy CRAN UMR 7039, CNRS, Université de Lorraine, Nancy, France.; Department of Neuro-Oncology, CHRU-Nancy, Université de Lorraine, Nancy, France.
Taillandier L; Centre de Recherche en Automatique de Nancy CRAN UMR 7039, CNRS, Université de Lorraine, Nancy, France.; Department of Neuro-Oncology, CHRU-Nancy, Université de Lorraine, Nancy, France.
Imbert L; Department of Nuclear Medicine and Nancyclotep Imaging Platform, CHRU-Nancy, Université de Lorraine, Nancy, France.; IADI UMR 1254, INSERM, Université de Lorraine, Nancy, France.
Verger A; Department of Nuclear Medicine and Nancyclotep Imaging Platform, CHRU-Nancy, Université de Lorraine, Nancy, France.; IADI UMR 1254, INSERM, Université de Lorraine, Nancy, France.
Pokaż więcej
Źródło :
Frontiers in oncology [Front Oncol] 2021 Oct 05; Vol. 11, pp. 735257. Date of Electronic Publication: 2021 Oct 05 (Print Publication: 2021).
Typ publikacji :
Journal Article
Czasopismo naukowe
Tytuł :
Exploring the Expression and Prognostic Value of the TCP1 Ring Complex in Hepatocellular Carcinoma and Overexpressing Its Subunit 5 Promotes HCC Tumorigenesis.
Autorzy :
Liu J; Graduate School, Guangzhou University of Chinese Medicine, Guangzhou, China.; Department of Laboratory Medicine, General Hospital of Southern Theater Command of People's Liberation Army (PLA), Guangzhou, China.
Huang L; Department of Laboratory Medicine, General Hospital of Southern Theater Command of People's Liberation Army (PLA), Guangzhou, China.
Zhu Y; Graduate School, Guangzhou University of Chinese Medicine, Guangzhou, China.; Department of Laboratory Medicine, General Hospital of Southern Theater Command of People's Liberation Army (PLA), Guangzhou, China.
He Y; Graduate School, Guangzhou University of Chinese Medicine, Guangzhou, China.; Department of Laboratory Medicine, General Hospital of Southern Theater Command of People's Liberation Army (PLA), Guangzhou, China.
Zhang W; Department of Laboratory Medicine, General Hospital of Southern Theater Command of People's Liberation Army (PLA), Guangzhou, China.
Lei T; Graduate School, Guangzhou University of Chinese Medicine, Guangzhou, China.; Department of Laboratory Medicine, General Hospital of Southern Theater Command of People's Liberation Army (PLA), Guangzhou, China.
Xuan J; Department of Laboratory Medicine, General Hospital of Southern Theater Command of People's Liberation Army (PLA), Guangzhou, China.
Xiao B; Department of Laboratory Medicine, General Hospital of Southern Theater Command of People's Liberation Army (PLA), Guangzhou, China.; Qingyuan People's Hospital, The Sixth Affiliated Hospital of Guangzhou Medical University, Qingyuan, China.
Li L; Department of Laboratory Medicine, General Hospital of Southern Theater Command of People's Liberation Army (PLA), Guangzhou, China.; Qingyuan People's Hospital, The Sixth Affiliated Hospital of Guangzhou Medical University, Qingyuan, China.
Zhou Q; Department of Laboratory Medicine, General Hospital of Southern Theater Command of People's Liberation Army (PLA), Guangzhou, China.; Laboratory of Basic Medical Science, General Hospital of Southern Theater Command of PLA, Guangzhou, China.
Sun Z; Graduate School, Guangzhou University of Chinese Medicine, Guangzhou, China.; Department of Laboratory Medicine, General Hospital of Southern Theater Command of People's Liberation Army (PLA), Guangzhou, China.
Pokaż więcej
Źródło :
Frontiers in oncology [Front Oncol] 2021 Oct 05; Vol. 11, pp. 739660. Date of Electronic Publication: 2021 Oct 05 (Print Publication: 2021).
Typ publikacji :
Journal Article
Czasopismo naukowe
Tytuł :
Development of Models to Predict Postoperative Complications for Hepatitis B Virus-Related Hepatocellular Carcinoma.
Autorzy :
Bao M; State Key Laboratory of Genetic Engineering, Institute of Biostatistics, School of Life Sciences, Fudan University, Shanghai, China.
Zhu Q; Division of Hepatobiliary and Pancreatic Surgery, Department of Surgery, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China.; Department of Surgery, Shanghai Jiaotong University School of Medicine, Shanghai, China.
Aji T; Department of Hepatobiliary and Hydatid Surgery, The First Affiliated Hospital of Xinjiang Medical University, Urumqi, China.
Wei S; Clinical Laboratory Diagnostics, School of Public Health, Gansu University of Chinese Medicine, Lanzhou, China.
Tuergan T; Department of Hepatobiliary and Hydatid Surgery, The First Affiliated Hospital of Xinjiang Medical University, Urumqi, China.
Ha X; Department of Clinical Laboratory, The 940th Hospital of Joint Logistics Support Force of Chinese People's Liberation Army, Lanzhou, China.
Tulahong A; Department of Hepatobiliary and Hydatid Surgery, The First Affiliated Hospital of Xinjiang Medical University, Urumqi, China.
Hu X; Division of Hepatobiliary and Pancreatic Surgery, Department of Surgery, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China.
Hu Y; State Key Laboratory of Genetic Engineering, Institute of Biostatistics, School of Life Sciences, Fudan University, Shanghai, China.; Shanghai Center for Mathematical Sciences, Fudan University, Shanghai, China.
Pokaż więcej
Źródło :
Frontiers in oncology [Front Oncol] 2021 Oct 05; Vol. 11, pp. 717826. Date of Electronic Publication: 2021 Oct 05 (Print Publication: 2021).
Typ publikacji :
Journal Article
Czasopismo naukowe
Tytuł :
Prognostic Signatures of Alternative Splicing Events in Esophageal Carcinoma Based on TCGA Splice-Seq Data.
Autorzy :
Ye P; National Health Commission Key Laboratory of Otorhinolaryngology, Department of Otorhinolaryngology, Qilu Hospital of Shandong University, Jinan, China.
Yang Y; National Health Commission Key Laboratory of Otorhinolaryngology, Department of Otorhinolaryngology, Qilu Hospital of Shandong University, Jinan, China.
Zhang L; National Health Commission Key Laboratory of Otorhinolaryngology, Department of Otorhinolaryngology, Qilu Hospital of Shandong University, Jinan, China.
Zheng G; Department of Clinical Laboratory, Qilu Hospital of Shandong University, Jinan, China.
Pokaż więcej
Źródło :
Frontiers in oncology [Front Oncol] 2021 Oct 05; Vol. 11, pp. 658262. Date of Electronic Publication: 2021 Oct 05 (Print Publication: 2021).
Typ publikacji :
Journal Article
Czasopismo naukowe
Tytuł :
Yttrium-90 TOF-PET-Based EUD Predicts Response Post Liver Radioembolizations Using Recommended Manufacturer FDG Reconstruction Parameters.
Autorzy :
Hesse M; Nuclear Medicine, Cliniques universitaires Saint-Luc, Brussels, Belgium.
d'Abadie P; Nuclear Medicine, Cliniques universitaires Saint-Luc, Brussels, Belgium.
Lhommel R; Nuclear Medicine, Cliniques universitaires Saint-Luc, Brussels, Belgium.
Jamar F; Nuclear Medicine, Cliniques universitaires Saint-Luc, Brussels, Belgium.
Walrand S; Nuclear Medicine, Cliniques universitaires Saint-Luc, Brussels, Belgium.
Pokaż więcej
Źródło :
Frontiers in oncology [Front Oncol] 2021 Oct 05; Vol. 11, pp. 592529. Date of Electronic Publication: 2021 Oct 05 (Print Publication: 2021).
Typ publikacji :
Journal Article
Czasopismo naukowe
Tytuł :
Commentary: Increased CDC6 Expression Associates With Poor Prognosis in Patients With Clear Cell Renal Cell Carcinoma.
Autorzy :
Temiz MZ; Department of Urology, Bagcilar Training and Research Hospital, Istanbul, Turkey.
Pokaż więcej
Źródło :
Frontiers in oncology [Front Oncol] 2021 Oct 05; Vol. 11, pp. 730782. Date of Electronic Publication: 2021 Oct 05 (Print Publication: 2021).
Typ publikacji :
Journal Article
Czasopismo naukowe
Tytuł :
A Nomogram for Predicting Pathological Complete Response to Neoadjuvant Chemoradiotherapy Using Semiquantitative Parameters Derived From Sequential PET/CT in Locally Advanced Rectal Cancer.
Autorzy :
Pyo DH; Department of Surgery, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, South Korea.
Choi JY; Department of Nuclear Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, South Korea.
Lee WY; Department of Surgery, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, South Korea.; Department of Health Sciences and Technology, Samsung Advanced Institute for Health Sciences & Technology (SAIHST), Sungkyunkwan University, Seoul, South Korea.
Yun SH; Department of Surgery, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, South Korea.
Kim HC; Department of Surgery, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, South Korea.
Huh JW; Department of Surgery, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, South Korea.
Park YA; Department of Surgery, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, South Korea.
Shin JK; Department of Surgery, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, South Korea.
Cho YB; Department of Surgery, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, South Korea.; Department of Health Sciences and Technology, Samsung Advanced Institute for Health Sciences & Technology (SAIHST), Sungkyunkwan University, Seoul, South Korea.; Department of Biopharmaceutical Convergence, Sungkyunkwan University, Seoul, South Korea.
Pokaż więcej
Źródło :
Frontiers in oncology [Front Oncol] 2021 Oct 05; Vol. 11, pp. 742728. Date of Electronic Publication: 2021 Oct 05 (Print Publication: 2021).
Typ publikacji :
Journal Article
Czasopismo naukowe
Tytuł :
Detection of HPV and Human Chromosome Sites by Dual-Color Fluorescence In Situ Hybridization Reveals Recurrent HPV Integration Sites and Heterogeneity in Cervical Cancer.
Autorzy :
Xiong J; Department of Obstetrics and Gynecology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
Cheng J; Department of Obstetrics and Gynecology, Zhongnan Hospital, Wuhan University, Wuhan, China.
Shen H; Department of Obstetrics and Gynecology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
Ren C; Department of Obstetrics and Gynecology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
Wang L; Department of Obstetrics and Gynecology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
Gao C; Department of Obstetrics and Gynecology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
Zhu T; Department of Obstetrics and Gynecology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
Li X; Department of Obstetrics and Gynecology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
Ding W; Department of Obstetrics and Gynecology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
Zhu D; Department of Obstetrics and Gynecology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
Wang H; Department of Obstetrics and Gynecology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
Pokaż więcej
Źródło :
Frontiers in oncology [Front Oncol] 2021 Oct 05; Vol. 11, pp. 734758. Date of Electronic Publication: 2021 Oct 05 (Print Publication: 2021).
Typ publikacji :
Journal Article
Czasopismo naukowe
Tytuł :
Detailed Analysis and Radiomic Prediction of First Progression Sites of First-Line Targeted Therapy for EGFR-Mutant Lung Adenocarcinoma Patients With Systemic Metastasis.
Autorzy :
Li X; Department of Radiation Oncology, The First Affiliated Hospital of The University of Science and Technology of China (USTC), Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei, China.; Department of Radiation Oncology, Shanghai Chest Hospital, Shanghai Jiao Tong University, Shanghai, China.
Hou R; Department of Radiation Oncology, Shanghai Chest Hospital, Shanghai Jiao Tong University, Shanghai, China.; School of Biomedical Engineering, Shanghai Jiao Tong University, Shanghai, China.
Yu W; Department of Radiation Oncology, Shanghai Chest Hospital, Shanghai Jiao Tong University, Shanghai, China.
Zhu X; Department of Radiation Oncology, Shanghai Chest Hospital, Shanghai Jiao Tong University, Shanghai, China.
Li H; Department of Radiation Oncology, The First Affiliated Hospital of Bengbu Medical College and Tumor Hospital Affiliated to Bengbu Medical College, Bengbu, China.
Yang Y; Department of Engineering and Applied Physics of University of Science and Technology of China, Hefei, China.
Qian D; Department of Radiation Oncology, The First Affiliated Hospital of The University of Science and Technology of China (USTC), Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei, China.
Fu X; Department of Radiation Oncology, Shanghai Chest Hospital, Shanghai Jiao Tong University, Shanghai, China.
Pokaż więcej
Źródło :
Frontiers in oncology [Front Oncol] 2021 Oct 05; Vol. 11, pp. 757892. Date of Electronic Publication: 2021 Oct 05 (Print Publication: 2021).
Typ publikacji :
Journal Article
Czasopismo naukowe
Tytuł :
Efficacy and Response Biomarkers of Apatinib in the Treatment of Malignancies in China: A Review.
Autorzy :
Tian Z; Department of Orthopedics, The Affiliated Cancer Hospital of Zhengzhou University and Henan Cancer Hospital, Zhengzhou, China.
Niu X; Department of Orthopedic Oncology, Beijing Jishuitan Hospital, Beijing, China.
Yao W; Department of Orthopedics, The Affiliated Cancer Hospital of Zhengzhou University and Henan Cancer Hospital, Zhengzhou, China.
Pokaż więcej
Źródło :
Frontiers in oncology [Front Oncol] 2021 Oct 05; Vol. 11, pp. 749083. Date of Electronic Publication: 2021 Oct 05 (Print Publication: 2021).
Typ publikacji :
Journal Article; Review
Czasopismo naukowe
Tytuł :
MiR-873-5p: A Potential Molecular Marker for Cancer Diagnosis and Prognosis.
Autorzy :
Zou Y; Institute of Translational Medicine, Zhejiang University City College, Hangzhou, China.; Medical Genetics Center, Ningbo University School of Medicine, Ningbo, China.
Zhong C; Medical Genetics Center, Ningbo University School of Medicine, Ningbo, China.
Hu Z; Medical Genetics Center, Ningbo University School of Medicine, Ningbo, China.
Duan S; Institute of Translational Medicine, Zhejiang University City College, Hangzhou, China.; Medical Genetics Center, Ningbo University School of Medicine, Ningbo, China.; Department of Clinical Medicine, Zhejiang University City College School of Medicine, Hangzhou, China.
Pokaż więcej
Źródło :
Frontiers in oncology [Front Oncol] 2021 Oct 05; Vol. 11, pp. 743701. Date of Electronic Publication: 2021 Oct 05 (Print Publication: 2021).
Typ publikacji :
Journal Article; Review
Czasopismo naukowe
Tytuł :
Arsenic Trioxide Promotes Tumor Progression by Inducing the Formation of PGCCs and Embryonic Hemoglobin in Colon Cancer Cells.
Autorzy :
Li Z; Department of Pathology, Tianjin Union Medical Center, Tianjin, China.
Zheng M; Department of Pathology, Tianjin Union Medical Center, Tianjin, China.
Zhang H; Graduate School, Tianjin University of Traditional Chinese Medicine, Tianjin, China.
Yang X; Nankai University School of Medicine, Nankai University, Tianjin, China.
Fan L; Graduate School, Tianjin University of Traditional Chinese Medicine, Tianjin, China.
Fu F; Department of Pathology, Tianjin Union Medical Center, Tianjin, China.; Graduate School, Tianjin University of Traditional Chinese Medicine, Tianjin, China.
Fu J; Department of Pathology, Tianjin Union Medical Center, Tianjin, China.; Graduate School, Tianjin Medical University, Tianjin, China.
Niu R; Graduate School, Tianjin University of Traditional Chinese Medicine, Tianjin, China.
Yan M; Graduate School, Tianjin University of Traditional Chinese Medicine, Tianjin, China.
Zhang S; Department of Pathology, Tianjin Union Medical Center, Tianjin, China.
Pokaż więcej
Źródło :
Frontiers in oncology [Front Oncol] 2021 Oct 05; Vol. 11, pp. 720814. Date of Electronic Publication: 2021 Oct 05 (Print Publication: 2021).
Typ publikacji :
Journal Article
Czasopismo naukowe
Tytuł :
Prognostic Value of Pretreatment Prognostic Nutritional Index in Patients With Renal Cell Carcinoma: A Meta-Analysis.
Autorzy :
Mao C; Department of Nephrology, Jiading District Central Hospital Affiliated Shanghai University of Medicine & Health Sciences, Shanghai, China.
Xu W; Department of Laboratory Medicine, Jiading District Central Hospital Affiliated Shanghai University of Medicine & Health Sciences, Shanghai, China.
Ma W; Department of Pharmacy, Jiading District Central Hospital Affiliated Shanghai University of Medicine & Health Sciences, Shanghai, China.
Wang C; Department of Oncology, Jiading District Central Hospital Affiliated Shanghai University of Medicine & Health Sciences, Shanghai, China.
Guo Z; Department of Oncology, Jiading District Central Hospital Affiliated Shanghai University of Medicine & Health Sciences, Shanghai, China.
Yan J; Department of Oncology, Jiading District Central Hospital Affiliated Shanghai University of Medicine & Health Sciences, Shanghai, China.
Pokaż więcej
Źródło :
Frontiers in oncology [Front Oncol] 2021 Oct 05; Vol. 11, pp. 719941. Date of Electronic Publication: 2021 Oct 05 (Print Publication: 2021).
Typ publikacji :
Systematic Review
Tytuł :
Mandibular Reconstruction With Fibula Flap and Dental Implants Through Virtual Surgical Planning and Three Different Techniques: Double-Barrel Flap, Implant Dynamic Navigation and CAD/CAM Mesh With Iliac Crest Graft.
Autorzy :
Antúnez-Conde R; Maxillofacial Surgery Department, Hospital General Universitario Gregorio Marañón, Madrid, Spain.
Salmerón JI; Maxillofacial Surgery Department, Hospital General Universitario Gregorio Marañón, Madrid, Spain.
Díez-Montiel A; Maxillofacial Surgery Department, Hospital General Universitario Gregorio Marañón, Madrid, Spain.
Agea M; Maxillofacial Surgery Department, Hospital General Universitario Gregorio Marañón, Madrid, Spain.
Gascón D; Maxillofacial Surgery Department, Hospital General Universitario Gregorio Marañón, Madrid, Spain.
Sada Á; Maxillofacial Surgery Department, Hospital General Universitario Gregorio Marañón, Madrid, Spain.
Navarro Cuéllar I; Maxillofacial Surgery Department, Hospital General Universitario Gregorio Marañón, Madrid, Spain.
Tousidonis M; Maxillofacial Surgery Department, Hospital General Universitario Gregorio Marañón, Madrid, Spain.
Ochandiano S; Maxillofacial Surgery Department, Hospital General Universitario Gregorio Marañón, Madrid, Spain.
Arenas G; Maxillofacial Surgery Department, Hospital General Universitario Gregorio Marañón, Madrid, Spain.
Navarro Cuéllar C; Maxillofacial Surgery Department, Hospital General Universitario Gregorio Marañón, Madrid, Spain.
Pokaż więcej
Źródło :
Frontiers in oncology [Front Oncol] 2021 Oct 05; Vol. 11, pp. 719712. Date of Electronic Publication: 2021 Oct 05 (Print Publication: 2021).
Typ publikacji :
Journal Article
Czasopismo naukowe
Tytuł :
Targeting the Tumor Extracellular Matrix by the Natural Molecule 4-Methylumbelliferone: A Complementary and Alternative Cancer Therapeutic Strategy.
Autorzy :
Vitale DL; Laboratorio de Microambiente Tumoral, Centro de Investigaciones Básicas y Aplicadas (CIBA), Universidad Nacional del Noroeste de la Provincia de Buenos Aires, Junin, Argentina.; Centro de Investigaciones y Transferencia del Noroeste de la Provincia de Buenos Aires (CITNOBA), Universidad Nacional del Noroeste de la Provincia de Buenos Aires (UNNOBA), Universidad Nacional de San Antonio de Areco (UNSAdA), Consejo Nacional de Investigaciones Científicas y Técnicas (CONICET), Pergamino, Argentina.
Icardi A; Laboratorio de Microambiente Tumoral, Centro de Investigaciones Básicas y Aplicadas (CIBA), Universidad Nacional del Noroeste de la Provincia de Buenos Aires, Junin, Argentina.; Centro de Investigaciones y Transferencia del Noroeste de la Provincia de Buenos Aires (CITNOBA), Universidad Nacional del Noroeste de la Provincia de Buenos Aires (UNNOBA), Universidad Nacional de San Antonio de Areco (UNSAdA), Consejo Nacional de Investigaciones Científicas y Técnicas (CONICET), Pergamino, Argentina.
Rosales P; Laboratorio de Microambiente Tumoral, Centro de Investigaciones Básicas y Aplicadas (CIBA), Universidad Nacional del Noroeste de la Provincia de Buenos Aires, Junin, Argentina.; Centro de Investigaciones y Transferencia del Noroeste de la Provincia de Buenos Aires (CITNOBA), Universidad Nacional del Noroeste de la Provincia de Buenos Aires (UNNOBA), Universidad Nacional de San Antonio de Areco (UNSAdA), Consejo Nacional de Investigaciones Científicas y Técnicas (CONICET), Pergamino, Argentina.
Spinelli FM; Laboratorio de Microambiente Tumoral, Centro de Investigaciones Básicas y Aplicadas (CIBA), Universidad Nacional del Noroeste de la Provincia de Buenos Aires, Junin, Argentina.; Centre de Recherche en Cancérologie et Immunologie Nantes Angers (CRCINA), Inserm, Centre National de la Recherche Scientifique (CNRS), Université de Nantes, Nantes, France.
Sevic I; Laboratorio de Microambiente Tumoral, Centro de Investigaciones Básicas y Aplicadas (CIBA), Universidad Nacional del Noroeste de la Provincia de Buenos Aires, Junin, Argentina.; Centro de Investigaciones y Transferencia del Noroeste de la Provincia de Buenos Aires (CITNOBA), Universidad Nacional del Noroeste de la Provincia de Buenos Aires (UNNOBA), Universidad Nacional de San Antonio de Areco (UNSAdA), Consejo Nacional de Investigaciones Científicas y Técnicas (CONICET), Pergamino, Argentina.
Alaniz LD; Laboratorio de Microambiente Tumoral, Centro de Investigaciones Básicas y Aplicadas (CIBA), Universidad Nacional del Noroeste de la Provincia de Buenos Aires, Junin, Argentina.; Centro de Investigaciones y Transferencia del Noroeste de la Provincia de Buenos Aires (CITNOBA), Universidad Nacional del Noroeste de la Provincia de Buenos Aires (UNNOBA), Universidad Nacional de San Antonio de Areco (UNSAdA), Consejo Nacional de Investigaciones Científicas y Técnicas (CONICET), Pergamino, Argentina.
Pokaż więcej
Źródło :
Frontiers in oncology [Front Oncol] 2021 Oct 04; Vol. 11, pp. 710061. Date of Electronic Publication: 2021 Oct 04 (Print Publication: 2021).
Typ publikacji :
Journal Article; Review
Czasopismo naukowe
Tytuł :
Diagnostic and Prognostic Potential of F-FET PET in the Differential Diagnosis of Glioma Recurrence and Treatment-Induced Changes After Chemoradiation Therapy.
Autorzy :
Celli M; Diagnostic Nuclear Medicine Unit, IRCCS Istituto Romagnolo per lo Studio dei Tumori (IRST) 'Dino Amadori', Meldola, Italy.
Caroli P; Diagnostic Nuclear Medicine Unit, IRCCS Istituto Romagnolo per lo Studio dei Tumori (IRST) 'Dino Amadori', Meldola, Italy.
Amadori E; Radiology MRI Unit, IRCCS Istituto Romagnolo per lo Studio dei Tumori (IRST) 'Dino Amadori', Meldola, Italy.
Arpa D; Radiation Therapy Unit, IRCCS Istituto Romagnolo per lo Studio dei Tumori (IRST) 'Dino Amadori', Meldola, Italy.
Gurrieri L; Oncology Unit, IRCCS Istituto Romagnolo per lo Studio dei Tumori (IRST) 'Dino Amadori', Meldola, Italy.
Ghigi G; Radiation Therapy Unit, IRCCS Istituto Romagnolo per lo Studio dei Tumori (IRST) 'Dino Amadori', Meldola, Italy.
Cenni P; Radiology MRI Unit, IRCCS Istituto Romagnolo per lo Studio dei Tumori (IRST) 'Dino Amadori', Meldola, Italy.
Paganelli G; Diagnostic Nuclear Medicine Unit, IRCCS Istituto Romagnolo per lo Studio dei Tumori (IRST) 'Dino Amadori', Meldola, Italy.
Matteucci F; Diagnostic Nuclear Medicine Unit, IRCCS Istituto Romagnolo per lo Studio dei Tumori (IRST) 'Dino Amadori', Meldola, Italy.
Pokaż więcej
Źródło :
Frontiers in oncology [Front Oncol] 2021 Oct 04; Vol. 11, pp. 721821. Date of Electronic Publication: 2021 Oct 04 (Print Publication: 2021).
Typ publikacji :
Journal Article
Czasopismo naukowe

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies